{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:54Z","timestamp":1761519054300,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.4158\/ep.14.4.432","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:18:38Z","timestamp":1365200318000},"page":"432-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Low Prostate-Specific Antigen Concentration and Panhypopituitarism"],"prefix":"10.1016","volume":"14","author":[{"given":"Andjela","family":"Drincic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Baltaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.4.432_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1464-410X.2006.06193.x","article-title":"Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer","volume":"98","author":"Chun","year":"2006","journal-title":"BJU Int."},{"key":"10.4158\/EP.14.4.432_bb0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","article-title":"Serum prostate-specific antigen in community-based population of healthy men","volume":"270","author":"Oesterling","year":"1993","journal-title":"JAMA."},{"key":"10.4158\/EP.14.4.432_bb0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199608013350502","article-title":"Age-specific reference ranges for serum prostate-specific antigen in black men","volume":"335","author":"Morgan TO","year":"1996","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.14.4.432_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate-specific antigen","volume":"21","author":"Balk","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.4158\/EP.14.4.432_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/edrv-8-3-338","article-title":"The endocrinology and developmental biology of the prostate","volume":"8","author":"Cuhna","year":"1987","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.14.4.432_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0303-7207(02)00374-X","article-title":"Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines","volume":"198","author":"Orio","year":"2002","journal-title":"Mol Cell Endocrinol."},{"key":"10.4158\/EP.14.4.432_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/me.2004-0208","article-title":"Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor","volume":"19","author":"Verras","year":"2005","journal-title":"Mol Endocrinol."},{"key":"10.4158\/EP.14.4.432_bb0040","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/endo.140.5.6721","article-title":"Evidence that insulin-like growth factor 1 and growth hormone are required for prostate gland development","volume":"140","author":"Ruan","year":"1999","journal-title":"Endocrinology."},{"key":"10.4158\/EP.14.4.432_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jcem-73-2-401","article-title":"Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells","volume":"73","author":"Cohen","year":"1991","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.4.432_bb0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2265.1994.tb03929.x","article-title":"Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls","volume":"40","author":"Behre","year":"1994","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.14.4.432_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-03-0102","article-title":"Serum insulin-like growth factor-1 is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer","volume":"13","author":"Oliver","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.4158\/EP.14.4.432_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science."},{"key":"10.4158\/EP.14.4.432_bb0065","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet."},{"key":"10.4158\/EP.14.4.432_bb0070","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1073\/pnas.0337496100","article-title":"Bajo Am, Varga JL. Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers","volume":"100","author":"Letsch","year":"2003","journal-title":"ProcNatl Acad Sci USA."},{"key":"10.4158\/EP.14.4.432_bb0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jcem.83.3.4645","article-title":"Prostatic hyperplasia: an unknown feature of acromegaly","volume":"83","author":"Colao","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.4.432_bb0080","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jcem.84.6.5776","article-title":"Effect of growth hormone (GH) and insulin-like growth factor 1 on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.4.432_bb0085","first-page":"3754","article-title":"Effect of two years of growth hormone and insulin-like growth factor-1 suppression on prostate diseases in acromegalic patients","volume":"85","author":"Coalo","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.4.432_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1430061","article-title":"Effect of GH and\/ or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients","volume":"143","author":"Colao","year":"2000","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP.14.4.432_bb0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/jc.2002-020812","article-title":"Effect of growth hormone (GH) and\/or testosterone replacement on the prostate in GH-deficient adult patients","volume":"88","author":"Colao","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.4.432_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/eje.0.1470059","article-title":"Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years","volume":"147","author":"le Roux","year":"2002","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP.14.4.432_bb0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20433075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20433075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/V7PN4185385311X8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:31Z","timestamp":1761515311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20433075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1530891X20433075"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.4.432","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Low Prostate-Specific Antigen Concentration and Panhypopituitarism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.4.432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}